Literature DB >> 19306501

NO more muscle fatigue.

Ahlke Heydemann1, Elizabeth McNally.   

Abstract

NOS is a key enzyme in the production of NO, a molecule that directly regulates vasorelaxation and blood supply. Diverse forms of muscle disease have been clinically associated with unusual fatigue after exercise. The localization of neuronal NOS (nNOS) at the plasma membrane of muscle has recently been shown to prevent muscle fatigue after exercise. In this issue of the JCI, Lai et al. show that dystrophin--the structural protein missing in individuals with Duchenne muscular dystrophy--anchors nNOS to the sarcolemma through a direct interaction with dystrophin spectrin-like repeats 16 and 17 (see the related article, doi:10.1172/JCI36612). Furthermore, in another recently reported study of mouse models of muscular dystrophy, phosphodiesterase 5A inhibitors were used to treat the downstream ischemia that is associated with nNOS mislocalization. Collectively, these findings significantly advance our understanding of exercise-induced muscle fatigue and its role in muscle disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19306501      PMCID: PMC2648689          DOI: 10.1172/jci38618

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies.

Authors:  R M Grady; R W Grange; K S Lau; M M Maimone; M C Nichol; J T Stull; J R Sanes
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

Review 2.  Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.

Authors:  Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

Review 3.  Exercise therapy in patients with myopathy.

Authors:  B A Phillips; F L Mastaglia
Journal:  Curr Opin Neurol       Date:  2000-10       Impact factor: 5.710

4.  Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle.

Authors:  G D Thomas; M Sander; K S Lau; P L Huang; J T Stull; R G Victor
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency.

Authors:  M Khairallah; R J Khairallah; M E Young; B G Allen; M A Gillis; G Danialou; C F Deschepper; B J Petrof; C Des Rosiers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

6.  Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.

Authors:  Yi Lai; Gail D Thomas; Yongping Yue; Hsiao T Yang; Dejia Li; Chun Long; Luke Judge; Brian Bostick; Jeffrey S Chamberlain; Ronald L Terjung; Dongsheng Duan
Journal:  J Clin Invest       Date:  2009-02-23       Impact factor: 14.808

7.  Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain.

Authors:  Glen B Banks; Paul Gregorevic; James M Allen; Eric E Finn; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2007-06-22       Impact factor: 6.150

8.  Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.

Authors:  Bert Blaauw; Cristina Mammucari; Luana Toniolo; Lisa Agatea; Reimar Abraham; Marco Sandri; Carlo Reggiani; Stefano Schiaffino
Journal:  Hum Mol Genet       Date:  2008-08-27       Impact factor: 6.150

9.  Sarcolemma-localized nNOS is required to maintain activity after mild exercise.

Authors:  Yvonne M Kobayashi; Erik P Rader; Robert W Crawford; Nikhil K Iyengar; Daniel R Thedens; John A Faulkner; Swapnesh V Parikh; Robert M Weiss; Jeffrey S Chamberlain; Steven A Moore; Kevin P Campbell
Journal:  Nature       Date:  2008-10-26       Impact factor: 49.962

10.  Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice.

Authors:  Justin M Percival; Kendra N E Anderson; Paul Gregorevic; Jeffrey S Chamberlain; Stanley C Froehner
Journal:  PLoS One       Date:  2008-10-13       Impact factor: 3.240

View more
  15 in total

1.  The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports.

Authors:  Félix Gómez-Gallego; Jonatan R Ruiz; Amaya Buxens; Marta Artieda; David Arteta; Catalina Santiago; Gabriel Rodríguez-Romo; José I Lao; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2009-08-22       Impact factor: 3.078

2.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

Review 3.  Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease.

Authors:  Cleva Villanueva; Cecilia Giulivi
Journal:  Free Radic Biol Med       Date:  2010-04-11       Impact factor: 7.376

4.  Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy.

Authors:  Karima Relizani; Etienne Mouisel; Benoit Giannesini; Christophe Hourdé; Ketan Patel; Susanne Morales Gonzalez; Kristina Jülich; Alban Vignaud; France Piétri-Rouxel; Dominique Fortin; Luis Garcia; Stéphane Blot; Olli Ritvos; David Bendahan; Arnaud Ferry; Renée Ventura-Clapier; Markus Schuelke; Helge Amthor
Journal:  Mol Ther       Date:  2014-05-27       Impact factor: 11.454

5.  Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Pam M Van Ry; Ryan D Wuebbles; Megan Key; Dean J Burkin
Journal:  Mol Ther       Date:  2015-06-08       Impact factor: 11.454

6.  Distinct genetic regions modify specific muscle groups in muscular dystrophy.

Authors:  Kayleigh A Swaggart; Ahlke Heydemann; Abraham A Palmer; Elizabeth M McNally
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

7.  Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.

Authors:  Jasmine Eshragh; Anand Dhruva; Steven M Paul; Bruce A Cooper; Judy Mastick; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Kord M Kober
Journal:  J Pain Symptom Manage       Date:  2016-10-05       Impact factor: 3.612

8.  Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.

Authors:  Genri Kawahara; Molly J Gasperini; Jennifer A Myers; Jeffrey J Widrick; Alal Eran; Peter R Serafini; Matthew S Alexander; Mathew T Pletcher; Carl A Morris; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2013-11-13       Impact factor: 6.150

Review 9.  Genes for elite power and sprint performance: ACTN3 leads the way.

Authors:  Nir Eynon; Erik D Hanson; Alejandro Lucia; Peter J Houweling; Fleur Garton; Kathryn N North; David J Bishop
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

Review 10.  Fatigue in muscular dystrophies.

Authors:  Corrado Angelini; Elisabetta Tasca
Journal:  Neuromuscul Disord       Date:  2012-12       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.